Cite
A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism.
MLA
Ghazanfari, Davoud, et al. “A Novel GSK-3 Inhibitor Binds to GSK-3β via a Reversible, Time and Cys-199-Dependent Mechanism.” Bioorganic & Medicinal Chemistry, vol. 40, June 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bmc.2021.116179.
APA
Ghazanfari, D., Noori, M. S., Bergmeier, S. C., Hines, J. V., McCall, K. D., & Goetz, D. J. (2021). A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism. Bioorganic & Medicinal Chemistry, 40, N.PAG. https://doi.org/10.1016/j.bmc.2021.116179
Chicago
Ghazanfari, Davoud, Mahboubeh S. Noori, Stephen C. Bergmeier, Jennifer V. Hines, Kelly D. McCall, and Douglas J. Goetz. 2021. “A Novel GSK-3 Inhibitor Binds to GSK-3β via a Reversible, Time and Cys-199-Dependent Mechanism.” Bioorganic & Medicinal Chemistry 40 (June): N.PAG. doi:10.1016/j.bmc.2021.116179.